Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 7:15 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Pregnancy Related, Hypertension
Interventions: Usual Care, ACHIEVE Multi-component Implementation Strategy; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 0 Years to 99 Years
Enrollment: 5,677 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 8
States / cities: Burlington, North Carolina • Chapel Hill, North Carolina • Durham, North Carolina + 2 more

Conditions: Gonorrhea, Chlamydia Infections, Hepatitis B, Hepatitis C, Diabetes Mellitus, Hypertension, Obesity, HIV Infections, Hyperlipidemia
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years and older
Enrollment: 294 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Cardiovascular Diseases, Metabolic Syndrome X, Hypertension, Inflammation, Atherosclerosis
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 20 Years to 32 Years
Enrollment: 4,362 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Glaucoma, Ocular Hypertension, Open Angle Glaucoma
Interventions: Nanodropper; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Glaucoma, Open-Angle
Interventions: Video education on proper eye drop instillation technique, Placebo video education on healthy eating tips; Other
Lead sponsor: Northwestern University; Other
Eligibility: 40 Years to 85 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypertension, Prehypertension
Interventions: MB-BP, Enhanced Usual Care Control; Behavioral · Other
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
Interventions: Not listed
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 7 Years to 100 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Diabetes, Hyperlipidemia, Hypertension, Cardiovascular Disease
Interventions: CVRS Intervention; Behavioral
Lead sponsor: Korey Kennelty; Other
Eligibility: 55 Years and older
Enrollment: 402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 18
States / cities: Gainesville, Florida • Tampa, Florida • Pocatello, Idaho + 14 more

Conditions: Sedentary Behavior, Exercise, Walking, Motivation, Hypertension, Depression, Body Mass Index
Interventions: Walking; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 69 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Hypertension in Pregnancy
Interventions: Docosahexaenoic acid 200 mg, Docosahexaenoic acid 1000 mg; Dietary Supplement · Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Pulmonary Arterial Hypertension
Interventions: Noninvasive actigraphy monitor; Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Cancer Survivor, Diabetes Mellitus, Hypertension
Interventions: computed tomography, cytology specimen collection procedure, laboratory biomarker analysis, questionnaire administration; Procedure · Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 45 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Duarte, California

Conditions: Hypertension, Pregnancy
Interventions: ultrasound evaluation in pregnancy; Procedure
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Sleep, Circadian Rhythm, Blood Pressure, Hypertension
Interventions: Constant Routine Protocol; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 1,427 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Albuminuria
Interventions: Ramipril + Irbesartan, Ramipril + Placebo; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 55 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 11
States / cities: Tustin, California • Miami, Florida • West Palm Beach, Florida + 8 more

Conditions: Glaucoma
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Surgery
Interventions: Esophageal pressure measurement guided ventilation; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity, High Blood Pressure, High Cholesterol, Type2 Diabetes, Heart Diseases
Interventions: Curcumin; Dietary Supplement
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Primary Open Angle Glaucoma, Ocular Hypertension
Interventions: T-2345, Xalatan; Drug
Lead sponsor: Nephron Pharmaceuticals Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 335 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Primary Open-angle Glaucoma
Interventions: iStent inject, Cataract surgery; Device · Procedure
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 45 Years and older
Enrollment: 505 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Racine, Wisconsin

Conditions: Hypertension
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 21 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Eye Diseases, Myopia, Glaucoma
Interventions: DREAM OCT; Device
Lead sponsor: Robert T. Chang, MD; Other
Eligibility: 18 Years and older
Enrollment: 154 participants
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pulmonary Hypertension
Interventions: BQ-123; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Infant, Newborn, Hypertension, Pulmonary, Persistent Fetal Circulation Syndrome, Pneumonia, Aspiration, Respiratory Distress Syndrome, Newborn, Respiratory Insufficiency
Interventions: Inhaled nitric oxide, Placebo; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 14 Days
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 1998
U.S. locations: 11
States / cities: Palo Alto, California • New Haven, Connecticut • Washington D.C., District of Columbia + 8 more

Search by objective public record fields.

Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle

Risk Assessment of Long-Haul Truck Drivers

Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults

Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma

Glaucoma Eye Drop Instillation: Impact of Education

UH3 Phase - Mindfulness-Based Blood Pressure Reduction (MB-BP) : Stage 2a RCT

OCT in Rare Chorioretinal Diseases

MEDication Focused Outpatient Care for Underutilization of Secondary Prevention

Multiphase Optimization Trial of Incentives for Veterans to Encourage Walking

Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health

HRV as a Marker of Treatment Response in PAH Arterial Hypertension

Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant

Comparison Fetal Hemodynamic Measurements Antihypertensive Versus Control

Sleep and Circadian Contributions to Nighttime Blood Pressure

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

Intraocular Pressure (IOP) Changes Associated With Muslim Prayer Postural Changes

Esophageal Balloon Measurements to Better Characterize Thoraco-abdominal Interrelationship Mechanics.

Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome

Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery

Genetic Analysis of African-Americans With High Blood Pressure

Swept Source OCT Imaging With the DREAM VG-OCT

The Role of Endothelin in Pulmonary Hypertension

Inhaled Nitric Oxide Study for Respiratory Failure in Newborns